Bogart Wealth’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-50
Closed -$599 – 2140
2026
Q2
$599 Buy
+50
New +$415 ﹤0.01% 1736

Other funds holding RGNX

Bogart Wealth's RGNX Position: Q3 2026 in Review

Bogart Wealth sold out of Regenxbio (RGNX) in Q3 2026, closing a stake of 50 shares — an estimated $599 sold.

Bogart Wealth first reported a position in RGNX in Q2 2026 and held it in 1 quarter. The position peaked at $599 in Q2 2026. 174 funds tracked by Wall St. Rank hold RGNX as of Q3 2026.

  • Bogart Wealth reported no remaining Regenxbio position as of Q3 2026 after selling out during the quarter.
  • Bogart Wealth sold 50 Regenxbio shares in Q3 2026, an estimated $599.
  • Bogart Wealth first reported a position in Regenxbio in Q2 2026 and held it in 1 quarter.
  • Bogart Wealth's Regenxbio position peaked at $599 in Q2 2026.
  • 174 funds tracked by Wall St. Rank held Regenxbio as of Q3 2026.

Based on Bogart Wealth's 13F filing for Q3 2026, filed 10 Nov 2026.